Herantis Pharma Plc’s financial reporting schedule and annual general meeting in 2016
Herantis Pharma Plc.
Company release 10 December 2015 at 9:00 am
Herantis Pharma Plc (“Herantis”) will publish its Financial Statements in regard to 2015 on the 25th of February 2016. The financial reporting schedule of Herantis in 2016 is as follows:
- Financial Statements bulletin in regard to 2015 on Thursday the 25th of February 2016
- Interim Report on January-June 2016 on Thursday the 25th of August 2016
The Annual General Meeting is planned to be held on Monday the 11th of April 2016. The Board of Directors will present a formal notice at a later stage.
Annual Report for 2015 will be published during the week 11/2016 in electronic format on the company’s web site.
Herantis Pharma Plc., Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 2538 0254
About Herantis Pharma Plc.
Herantis Pharma Plc. is a pharmaceutical company specialised in new drug research and development. The company focuses on diseases with an unmet clinical need. These diseases include for example Parkinson’s disease and secondary lymphedema. The shares of Herantis are listed on the First North Finland marketplace run by Nasdaq Helsinki stock exchange.